This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Sinovac Biotech Ltd (SVA)

NASDAQ: Health Care

Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) 10.37M -18.75M -399.69K -12.60M
Operating Gains/Losses 0.00 0.00 0.00 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -7.26M -4.29M 5.47M 1.00M
(Increase) Decrease in Inventories -7.55M -425.85K -1.92M -8.60M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 4.55M -967.67K 1.20M -686.46K
(Decrease) Increase In Other Current Liabilities -668.00K -3.13M -1.36M 0.00
(Increase) Decrease In Other Working Capital 0.00 1.03M 0.00 -5.10M
Other Non-Cash Items 1.26M 4.66M 3.41M 9.97M
Net Cash From Continuing Operations 5.58M -16.25M 13.94M -14.28M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 5.58M -16.25M 13.94M -14.28M
Sale of Property, Plant & Equipment 0.00 5.38K 122.09K 231.61K
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 1.54M 7.31M
Purchases of Property, Plant & Equipment -5.18M -16.16M -15.46M -25.38M
Acquisitions 0.00 0.00 0.00 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 -1.48M
Other Cash from Investing Activities 0.00 0.00 0.00 64.40K
Cash Provided by Financing Activities
Net Cash From Investing Activities -5.18M -16.15M -13.79M -19.24M
Issuance of Debt 16.80M 15.22M 11.39M 19.99M
Cash Used for Financing Activities
Issuance of Capital Stock 848.00K 515.68K 752.16K 62.26M
Repayment of Long-Term Debt 0.00 0.00 -10.66M -17.85M
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 -802.15K -5.86M -3.29M
Other Financing Charges, Net -3.23M 2.39M 4.99M -2.91M
Net Cash From Financing Activities 14.42M 17.33M 612.93K 58.19M
Effect of Exchange Rate Changes 1.18M 2.03M 1.94M 1.96M
Net Change in Cash & Cash Equivalents 16.00M -13.05M 2.70M 26.63M
SVA News

SVA Sinovac Biotech Ltd

Analysts Ratings for SVA

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET SVA ANALYST REPORT

Brokerage Partners

SVA Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs